Literature DB >> 20581579

Successful treatment with erlotinib after gefitinib-induced severe interstitial lung disease.

Masayuki Takeda1, Isamu Okamoto, Chihiro Makimura, Masahiro Fukuoka, Kazuhiko Nakagawa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20581579     DOI： 10.1097/JTO.0b013e3181d89ac2

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN： 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  7 in total

1.  Successful treatment with afatinib after gefitinib- and erlotinib-induced hepatotoxicity.

Authors:  Hiroto Ueda; Hidetoshi Hayashi; Keita Kudo; Masayuki Takeda; Kazuhiko Nakagawa
Journal:  Invest New Drugs       Date:  2016-08-23       Impact factor: 3.850

2.  Successful Use of Afatinib After Erlotinib-induced Pneumonitis in a Patient With Epidermal Growth Factor Receptor-mutant Lung Cancer.

Authors:  Christopher D Jakubowski; Andrew J Plodkowski; Jason C Chang; Natasha Rekhtman; Afsheen Iqbal; Paul K Paik; Helena A Yu
Journal:  Clin Lung Cancer       Date:  2016-10-26       Impact factor: 4.785

3.  Re-administration of Chemotherapy in Patients with Advanced Non-small Cell Lung Cancer Who Recovered from Chemotherapy-induced Interstitial Lung Disease.

Authors:  Kosuke Kashiwabara; Hiroshi Semba; Shinji Fujii; Shinsuke Tsumura
Journal:  In Vivo       Date:  2018 Jul-Aug       Impact factor: 2.155

4.  Successful Osimertinib Rechallenge with Steroid Therapy after Osimertinib-induced Interstitial Lung Disease.

Authors:  Tatsunori Kiriu; Daisuke Tamura; Motoko Tachihara; Reina Sekiya; Daisuke Hazama; Masahiro Katsurada; Kyosuke Nakata; Tatsuya Nagano; Masatsugu Yamamoto; Hiroshi Kamiryo; Kazuyuki Kobayashi; Yoshihiro Nishimura
Journal:  Intern Med       Date:  2017-10-16       Impact factor: 1.271

5.  Gefitinib successfully administered in a lung cancer patient with leptomeningeal carcinomatosis after erlotinib-induced pneumatosis intestinalis.

Authors:  Hironori Uruga; Shuhei Moriguchi; Yui Takahashi; Kazumasa Ogawa; Kyoko Murase; Sayaka Mochizuki; Shigeo Hanada; Hisashi Takaya; Atsushi Miyamoto; Nasa Morokawa; Kazuma Kishi
Journal:  BMC Cancer       Date:  2018-08-16       Impact factor: 4.430

6.  Chemotherapy-Associated Pulmonary Toxicity-Case Series from a Single Center.

Authors:  Tilak Tvsvgk; Ajay Handa; Kishore Kumar; Deepti Mutreja; Shankar Subramanian
Journal:  South Asian J Cancer       Date:  2021-11-11

7.  Successful osimertinib rechallenge after osimertinib-induced pneumonitis in a patient with lung adenocarcinoma.

Authors:  Shingo Satoh; Takayuki Shiroyama; Motohiro Tamiya; Shingo Nasu; Ayako Tanaka; Satomu Morita; Naoko Morishita; Hidekazu Suzuki; Norio Okamoto; Tomonori Hirashima
Journal:  Respir Med Case Rep       Date:  2017-12-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.